Summary
The effectiveness of a surveillance program for breast cancer recurrence in extending survival is predicated on two assumptions: 1) most recurrences are detected at an early stage at surveillance visits; and 2) the early treatment of recurrence offers a better chance of cure or longer survival. However, the data suggest that neither of these two assumptions is correct, and that postoperative follow-up of patients with breast cancer is expensive and does not significantly extend survival.
Similar content being viewed by others
References
Zwaveling A, Albers GMR, Felthuis W, et al: An evaluation of routine follow up for detection of breast cancer recurrences. J Surg Oncol 34:194–197, 1987
Pandya KJ, McFadden ET, Kalish LA, et al: A retrospective study of earliest indicators of recurrence in Patients on Eastern Cooperative Oncology Group Adjuvant Chemotherapy Trials for breast cancer. Cancer 55:202–205, 1985
Scanlon EF, Ovieda MA, Cunningham MP, et al: Preoperative and follow up procedures on patients with breast cancer. Cancer 46:977–979, 1980
Broyn T, Froyen J: Evaluation of routine follow up after surgery for breast carcinoma. Acta Chir Scand 148:401–404, 1982
Winchester DP, Sener SF, Khanderkar JD: Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer 43:956–960, 1979
Baker RR, Holmes ER, Anderson PO, et al: An evaluation of bone scans as screening procedures for occult metastases in primary breast cancer. Ann Surg 186: 363, 1977
Burkett FE, Scanlon EF, Garces RM, et al: The value of bone scans in the management of patients with carcinoma of the breast. Surg Gynecol Obstet 149: 523–525, 1979
McNeil B, Pace PD, Gray E, et al: Pre-operative and follow up bone scans in patients with primary carcinoma of the breast. Surg Gynecol Obstet 147:745–748, 1978
O'Connell MJ, Wahner HW, Ahmann DL, et al. Value of preoperative radionucleotide bone scans in suspected primary breast cancer. Mayo Clinic Proc 53:221, 1978
Wickerham L, Fisher B, Cronin W, et al: The efficacy of bone scanning in the follow-up of patients with operable breast cancer. Breast Cancer Res Treat 4:303–307, 1984
Pedrazzini A, Gelbes R, Isley M, et al: First repeated bone scan in the observation of patients with operable breast cancer. J Clin Oncol 4:389–394, 1986
Perez D, Milan J, Powles T, et al: Detection of breast carcinoma metastases in bone: Relative merits of x-rays and skeletal scintigraphy. Lancet ii:613–616, 1983
Rossing N, Munck O, Nielsen S, et al: What do early bone scans tell about breast cancer patients? Eur J Cancer Clin Oncol 18:629–636, 1982
Corcoran RJ, Thrall JH, Kyle RW, et al: Solitary abnormalities in bone scans of patients with extraosseous malignancies. Radiology 121:663–667, 1976
Hartunian N, Smart C, Thompson M: The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: A comparative analysis. Am J Publ Health 70:1249–1260, 1980
Hodgson TA, Meiners MR: Cost-of-illness methodology: A guide to current practice and procedures. Milbank Memorial Fund Quarterly 60:429–462, 1982
Warner KE, Luce BR: Cost-benefit and cost-effectiveness analysis in health care: Principles, practice, and potential. Health Admin Press, Ann Arbor, Michigan, 1982.
Russell LB: Is prevention better than cure? The Brookings Institution, Washington DC, 1986.
American Cancer Society: Cancer Facts and Figures. New York A.C.S., Inc., 1983.
Holland JF: Karnofsky Memorial Lecture: Breaking the cure barrier. J Clin Oncol 1:74–90, 1983
Legha SS, Buzdar AU, Smith TL, et al: Complete remissions in metastatic breast cancer treated with combination drug therapy. Ann Int Med 91:847–852, 1979
Blumenschein GR, Buzdar AU, Yap HY, et al: Seven year follow up of Stage IV patients entering complete remissions from FAC. 3rd E.O.R.T.C. Working Conference IX, 43, 1983
Lippman ME, Lichter AS, Danforth DN: Diagnosis and management of breast cancer. WB Saunders Co, 1988, pp 375-406
Author information
Authors and Affiliations
Additional information
This minisymposium was presented December 8, 1992, at the annual San Antonio Breast Cancer Symposium, and was sponsored by educational grants from Amgen and from Bristol-Myers Oncology Division.
Rights and permissions
About this article
Cite this article
Schapira, D.V. Breast cancer surveillance — a cost-effective strategy. Breast Cancer Res Tr 25, 107–111 (1993). https://doi.org/10.1007/BF00662135
Issue Date:
DOI: https://doi.org/10.1007/BF00662135